Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $32.70 USD
Change Today +1.21 / 3.84%
Volume 2.4M
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter S. Ringrose Ph.D.

Member of Scientific Advisory Board, Cempra, Inc.
AgeTotal Calculated CompensationThis person is connected to 60 board members in 5 different organizations across 9 different industries.

See Board Relationships
68$666,440

Background*

Dr. Peter S. Ringrose, Ph.D., is an Advisor of Excalibur Fund Managers Limited. Dr. Ringrose has been Scientific Advisor of Rigel Pharmaceuticals, Inc. since February 2, 2005. Dr. Ringrose served as the President of Pharmaceutical Research Institute and Chief Scientific Officer of Bristol Myers Squibb Co. from January 2000 to December 2002. Dr. Ringrose served as Scientific Advisor of Bristol-Myers Squibb Co. since January 2, 2003. He joined Bristol-Myers Squibb in January ...

Read Full Background

Corporate Headquarters*

6320 Quadrangle Drive
Chapel Hill, North Carolina 27517

United States

Phone: 919-313-6601
Fax: --

Board Members Memberships*

Director
2001-N/A
Former Member of Board of Directors
2003-N/A
Former Chairman of Scientific Advisory Board
2005-Present
Director, Member of Nominating and Corporate Governance Committee and Member of Compensation Committee
2007-Present
Non Executive Director
2010-2014
Former Director, Member of Science & Technology Advisory Committee and Member of Compensation Committee
2013-Present
Director, Chairman of Science & Technology Committee and Member of Compensation Committee

Education*

MA
University of Cambridge
PhD 1970
University of Cambridge
BS
University of Cambridge

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options24,000
Total Number of Options24,000

Total Compensation*

Total Annual Cash Compensation$80,797
Total Calculated Compensation$666,440
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CEMP:US $32.70 USD +1.21

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Clive A. Meanwell M.D., Ph.D.Chairman and Chief Executive Officer
The Medicines Company
$874.6K
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
$500.0K
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CEMPRA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.